FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

FDA Rolling Out IT Modernization Plan Shortly

FDA acting commissioner Ned Sharpless says the agency is just weeks away from announcing a new plan to modernize its technology infrastructure to help...

Human Drugs

FDA Denies Petition Seeking New Opioid Moratorium

FDA denies a 3/21 citizen petition from advocacy group Public Citizen that urged the agency to immediately impose a moratorium on approval of any new ...

Medical Devices

2 FDA Guidances on De Novo Device Requests

FDA issues two guidances related to medical device de novo classification requests one on performance goals and the other on user fee refund requests...

FDA General

FDA Hits Juul with Warning Letter

FDA issues a Warning Letter to Juul Labs over marketing unauthorized modified risk tobacco products.

Human Drugs

FDA Quality Guide on Real World Data Coming

FDA says it is developing guidance on data quality issues that pertain to real world data and related study design considerations.

Human Drugs

GAO Report on Patient Access to Investigational Drugs

A new GAO report finds that FDA has ongoing efforts to help drug manufacturers identify the circumstances under which they could broaden clinical tria...

Federal Register

Reg Review Period for Glaxos Shingrix Vaccine

Federal Register notice: FDA determines the regulatory review period for patent extension purposes for GlaxoSmithKline Biologicals Shingrix vaccine.

Federal Register

Guide on Humanitarian Device Exemption Program

Federal Register notice: FDA makes available a final guidance entitled Humanitarian Device Exemption (HDE) Program.

Federal Register

Priority Voucher Used on Rinvoq Approval

Federal Register notice: FDA announces that it accepted a priority review voucher to approve AbbVies Rinvoq (upadacitnib) on 8/16.

Human Drugs

Woodcock Urges Better Drug Compounding Safety Reports

CDER director Janet Woodcock urges drug compounding outsourcing facilities to appropriately label their drugs with adverse event reporting information...